Sitagliptin Intermediate 2

CAS No. 762240-92-6

Sitagliptin Intermediate 2( —— )

Catalog No. M35297 CAS No. 762240-92-6

Sitagliptin Intermediate 2 is a useful organic compound that has been used in life science related research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1G 26 Get Quote

Biological Information

  • Product Name
    Sitagliptin Intermediate 2
  • Note
    Research use only, not for human use.
  • Brief Description
    Sitagliptin Intermediate 2 is a useful organic compound that has been used in life science related research.
  • Description
    3-Trifluoromethyl-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine (hydrochloride) is a biochemical reagent that can be used as a biological material or organic compound for life science related research.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    762240-92-6
  • Formula Weight
    228.603
  • Molecular Formula
    C6H8ClF3N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (437.45 mM; Ultrasonic )
  • SMILES
    Cl.FC(F)(F)c1nnc2CNCCn12
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • RMC-6291

    RMC-6291 is an orally active, covalent inhibitor of KRAS G12C (ON) that forms a tri-complex within tumor cells between KRAS G12C (ON) and cyclophilin A (CypA), thereby preventing KRAS G12C (ON) from signaling via steric blockade of RAS effector binding and eliciting deep and durable suppression of RAS pathway activity in KRAS G12C tumor models .

  • Etiprednol dicloacet...

    Etiprednol dicloacetate (BNP-166) is a corticosteroid with anti-inflammatory activity.

  • ACT-389949

    ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.